Israel Englander Amgen Inc Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Amgen Inc stock. As of the latest transaction made, Millennium Management LLC holds 285,300 shares of AMGN stock, worth $75.1 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

285,300

Previous 67,207 324.51%

Holding current value

$75.1 Million

Previous $21 Million 337.78%

% of portfolio

0.05%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $11.5 Million - $12.5 Million	-37,194 Reduced 55.34%	30,013 $9.67 Million
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $969,022 - $1.18 Million	3,688 Added 5.81%	67,207 $21 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $53.6 Million - $64.7 Million	-199,303 Reduced 75.83%	63,519 $18.1 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $94.4 Million - $107 Million	-369,285 Reduced 58.42%	262,822 $75.7 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $123 Million - $146 Million	575,533 Added 1017.31%	632,107 $140 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $679,402 - $828,076	3,009 Added 5.62%	56,574 $13.7 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $5.99 Million - $7.61 Million	26,139 Added 95.31%	53,565 $14.1 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $183 Million - $206 Million	-813,802 Reduced 96.74%	27,426 $6.18 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $125 Million - $139 Million	542,713 Added 181.8%	841,228 $205 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $14.7 Million - $16.3 Million	67,250 Added 29.08%	298,515 $72.2 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $38.1 Million - $43.6 Million	191,605 Added 483.12%	231,265 $52 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $8.76 Million - $10.3 Million	-41,262 Reduced 50.99%	39,660 $8.43 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $10.7 Million - $11.8 Million	45,643 Added 129.38%	80,922 $19.7 Million
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $35.2 Million - $41 Million	-158,445 Reduced 81.79%	35,279 $8.78 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $41.6 Million - $49.5 Million	192,196 Added 12578.27%	193,724 $44.5 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $2.88 Million - $3.54 Million	-14,564 Reduced 90.5%	1,528 $360,000
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $2.74 Million - $3.63 Million	15,022 Added 1403.93%	16,092 $3.26 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $35.2 Million - $45.3 Million	-186,208 Reduced 99.43%	1,070 $258,000
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $10.2 Million - $12.2 Million	58,300 Added 45.2%	187,278 $36.2 Million
Q2 2019 Aug 15, 2019	SELL	$166.7 - $195.41 $11.4 Million - $13.3 Million	-68,293 Reduced 34.62%	128,978 $23.8 Million
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $103 Million - $121 Million	-618,040 Reduced 75.8%	197,271 $28.5 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $17.8 Million - $20.1 Million	-98,574 Reduced 10.79%	815,311 $155 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $90.1 Million - $105 Million	505,244 Added 123.64%	913,885 $178 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $15.6 Million - $17.6 Million	84,242 Added 25.97%	408,641 $84.7 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $51.9 Million - $58.3 Million	-312,411 Reduced 49.06%	324,399 $59.9 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $19.9 Million - $23.3 Million	117,669 Added 22.67%	636,810 $109 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $81.1 Million - $90.6 Million	480,551 Added 1245.27%	519,141 $90.3 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $6.46 Million - $7.37 Million	38,590	38,590 $7.2 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account